There is no evidence that NLGN-AS1 expression was abnormal in the carcinogenesis tissue of patients, the mechanism of NLGN-AS1 in tumors and other diseases, especially ccRCC, was also unclear. Here, NLGN4X is linked to nonpapillary renal cell carcinoma.